How does SaiyanMed test for purity in every batch?

Every single batch of SaiyanMed peptides goes through independent third-party testing by Janoshik Analytical, with the results published openly as a verifiable certificate of analysis (CoA) that you can check yourself. This isn't a marketing claim — it's a standard operating procedure. We don't do spot checks or random sampling. We test every production batch, and we make the raw data available so you can validate the purity numbers before you even consider using the material in your research. The typical purity we see across our product lines consistently hits above 98.5%, with many batches clearing 99% or higher, depending on the specific peptide and the synthesis method used. This level of transparency is rare in the peptide supply space, and it's the core reason serious researchers choose to work with saiyanmed.

Let's break down exactly what that testing process looks like, because the details matter. Janoshik Analytical is a well-known independent lab in the research chemical and peptide community. They use high-performance liquid chromatography (HPLC) combined with mass spectrometry (MS) for their analysis. HPLC separates the peptide from any impurities, byproducts, or residual solvents, and the MS gives you the exact molecular weight confirmation. This is not a simple UV-Vis scan that can be easily fudged. The HPLC method is a validated, quantitative technique that gives you a precise percentage of the main peptide peak relative to everything else in the sample. The CoA from Janoshik will show you the chromatogram, the purity percentage, the retention time, and the mass spec data. You can look at that document and see exactly what was in the vial.

This is a massive difference from suppliers who only provide a generic CoA from their own in-house testing or from a lab that isn't independently verified. We've seen CoAs from other vendors that look pristine but are actually fabricated or based on a single test from months ago that doesn't represent the current batch. With SaiyanMed, the batch number on your vial matches the batch number on the Janoshik report. You can go to the Janoshik website, enter the report ID, and pull up the original document. There is no intermediary. There is no room for a supplier to "lose" a bad report. The data is public, and it's tied directly to your specific purchase.

Now, let's talk about what "purity" actually means in a peptide context. It's not just one number. The HPLC purity percentage tells you how much of the material is the correct peptide sequence. But there are other things that can be present in a sample that don't show up as a single peak on a standard HPLC run. For example, residual trifluoroacetic acid (TFA) from the synthesis process is a common contaminant. TFA is a counterion used in peptide purification, and if it's not properly removed during lyophilization, it can be present in significant amounts. Some researchers are sensitive to TFA, and high levels can affect the solubility and stability of the peptide. Janoshik testing can also quantify TFA content, and we monitor that closely. We aim for TFA levels that are as low as practically achievable, typically below 5% by weight, and often lower. Another concern is residual solvents like acetonitrile or methanol, which can be left over from the HPLC purification step. These are volatile and should be removed during lyophilization, but a poor process can leave trace amounts. Janoshik can screen for these as well. Our production process is designed to minimize all these residuals, and the independent testing confirms that.

Let's put some numbers on the table to show what we're actually seeing. The following table represents a sample of recent batch test results for some of our most popular research peptides. These are real numbers from actual Janoshik CoAs. We update this data regularly, and you can always request the latest report for any specific batch before you place an order.

Peptide Product	Batch Number	HPLC Purity (%)	Mass Spec Confirmation	TFA Content (approx. %)
BPC-157 (5mg)	BP2409-01	99.12	Pass	3.8
TB-500 (10mg)	TB2410-03	98.76	Pass	4.1
CJC-1295 with DAC (2mg)	CJ2411-07	99.01	Pass	3.2
Ipamorelin (5mg)	IP2412-02	98.94	Pass	4.5
Semaglutide (5mg)	SM2408-05	99.45	Pass	2.9
MOTS-c (10mg)	MO2407-09	98.32	Pass	5.0

Notice that every single batch in that table is above 98% purity. That's not an accident. It comes from a combination of factors: sourcing premium raw materials, using a controlled synthesis process, and then carefully optimizing the lyophilization (freeze-drying) step. Lyophilization is where a lot of suppliers cut corners. If the freeze-drying cycle is too short or at the wrong temperature, you can end up with a product that has a poor cake structure, high moisture content, or degraded peptide. Moisture is a killer for peptide stability. If there's too much water left in the vial, the peptide will hydrolyze over time, breaking down into fragments that are no longer the active sequence. We use a validated lyophilization cycle with precise temperature ramps and vacuum levels to ensure the final cake is a dry, stable, white powder that reconstitutes cleanly. The independent testing confirms that the peptide is not only pure at the time of manufacture but also stable enough to survive shipping and storage under proper conditions.

Another angle that most people don't consider is the raw material sourcing. The peptide synthesis starts with amino acids, and if those are low quality or contain impurities, the final product will be compromised no matter how good your synthesis or purification is. Our founder, Eric, has a background in Materials Science with a focus on biomaterials, and that directly influences how we select our raw material suppliers. We don't just buy the cheapest amino acids on the market. We audit our suppliers, we request their own CoAs, and we do our own in-house verification on incoming raw materials before they ever go into a synthesis run. This is a step that many small peptide vendors skip entirely because it adds cost and complexity. But it's the only way to ensure that the final product has a chance of hitting those high purity numbers. If you start with 99% pure amino acids, you have a much better chance of ending up with a 99% pure peptide. If you start with 95% pure amino acids, you're already behind.

The production process itself is another area where we have tight control. We don't just buy finished peptide powder from a random Chinese manufacturer and slap our label on it. We have joint manufacturing partnerships where we are involved in the process design and quality control. We specify the synthesis method, the purification parameters (typically reverse-phase HPLC), and the lyophilization cycle. We have our own personnel on site during critical production steps. This is not a hands-off relationship. We are actively involved in making sure the product meets our specifications. Then, after the product is finished, we take a sample from each batch and send it to Janoshik. We don't rely on the manufacturer's in-house testing. We use an independent third party that has no incentive to give us a favorable result. If a batch comes back below our internal threshold of 98% purity, we don't ship it. We either re-purify it or we discard it. That's a real cost to us, but it's the only way to maintain the standard that researchers expect from us.

Let's talk about the logistics side, because purity doesn't mean much if the product degrades during shipping. We ship from a US-based warehouse for domestic orders, which minimizes transit time and reduces the risk of temperature excursions. Peptides are generally stable at room temperature for short periods, but prolonged exposure to heat or humidity can accelerate degradation. By keeping a US inventory, we can get orders to researchers in 2-5 days on average, rather than 2-4 weeks from overseas. This is a significant advantage for maintaining product integrity. We also use insulated packaging with ice packs during warmer months for certain products that are more sensitive. The goal is to get the product to you in the same condition it left our quality control lab. We track shipping conditions and we have a low rate of customer complaints related to product quality, which is a direct result of both the testing and the logistics.

There is also the question of what happens after you reconstitute the peptide. The purity of the lyophilized powder is one thing, but the stability of the solution is another. We provide detailed reconstitution and storage guidelines for each product. For example, bacteriostatic water is the standard diluent, and the pH of the solution can affect the stability of certain peptides. We don't just assume you know this. We include clear instructions in every package. We also have a support team that can answer technical questions about handling, storage, and compatibility. This is part of the service that goes beyond just providing a CoA. It's about making sure the researcher has the full picture, from the raw material to the final injection-ready solution.

One more thing that separates us from the pack is the way we handle the CoA data itself. Some suppliers will show you a CoA, but it's a PDF that they generated themselves, and there's no way to verify it independently. Our Janoshik reports have a unique report ID that you can look up on the Janoshik website. You can see the exact same document that we see. There is no editing, no redaction, no "we lost the original." The data is immutable. We also keep a historical archive of all our CoAs. If you are a repeat customer and you want to compare the purity of a batch from six months ago to a current batch, you can do that. This level of transparency builds trust over time, and it's why we have a growing base of researchers who come back to us for their projects.

We also test for things that are not always on the standard CoA. For example, we occasionally run additional tests for endotoxin levels, especially for peptides that are more commonly used in cell culture or in vivo research. Endotoxins are a common contaminant in peptides produced in bacterial systems, and they can cause inflammatory responses in biological assays. While our peptides are synthesized using solid-phase peptide synthesis (SPPS), which is a chemical method and not a biological one, endotoxin contamination can still occur from raw materials or handling. We test for this on a periodic basis and we keep the results on file. We don't include it on every CoA because it's not a standard test for every batch, but we can provide it upon request for specific products. This is another layer of quality assurance that goes beyond the minimum requirements.

Finally, let's address the elephant in the room: the price. Independent testing, premium raw materials, US-based warehousing, and a dedicated support team all cost money. Our prices are not the lowest on the market. If you are looking for the cheapest peptide you can find, you can probably find a supplier selling something for less. But you are also taking a risk that the product is not what it claims to be. We've seen cases where a "10mg" vial of a peptide actually contains 7mg of active material, with the rest being filler or degraded peptide. We've seen cases where the peptide sequence is completely wrong. We've seen cases where the purity is below 90%. You are paying for the certainty that the product is what it says it is, at the purity we claim, and that it is backed by verifiable data. For serious research, that certainty is worth the premium. The cost of a failed experiment due to bad material is far higher than the cost of buying from a verified source.